Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 2009 Feb 2;53(4):1709–1711. doi: 10.1128/AAC.01014-08

Transmission of IncN Plasmids Carrying blaCTX-M-1 between Commensal Escherichia coli in Pigs and Farm Workers

Arshnee Moodley 1,*, Luca Guardabassi 1
PMCID: PMC2663060  PMID: 19188380

Abstract

CTX-M-1-producing Escherichia coli were isolated from 56 pigs, three farm personnel, two manure samples, and two air samples from two Danish pig farms where an association between prophylactic ceftiofur use and the occurrence of cephalosporin resistance was previously demonstrated. Human, animal, and environmental strains displayed high genetic diversity but harbored indistinguishable or closely related IncN plasmids carrying blaCTX-M-1, indicating that IncN plasmids mediating cephalosporin resistance were transmitted between pigs and farm workers across multiple E. coli lineages.


Extended-spectrum cephalosporins have been classified by the World Health Organization as critically important antibiotics in human medicine (19). Ceftiofur is an extended-spectrum cephalosporin licensed for the treatment of respiratory infections in pigs and cattle. Various authors have hypothesized that the veterinary use of extended-spectrum cephalosporins may select for extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae in animals, resulting in an increased risk of the zoonotic transmission of ESBL-carrying bacteria and plasmids (2, 10, 11, 17, 18).

A statistical association between the prophylactic use of ceftiofur and the occurrence of cefotaxime-resistant E. coli in healthy pigs was recently demonstrated at two Danish pig farms, and most of the isolates were shown to be CTX-M-1 producers (11). In this study, we revisited the farms 1 year after the previous study to investigate the distribution, persistence, and transmission of blaCTX-M-1 between pigs, farm workers, and the farm environment. Fecal samples were randomly obtained from one sow-piglet pair or weaner in every fifth pen. Limited to one farm, composite manure samples were collected from pens containing slaughter pigs. Environmental surface swabs were collected from door handles, wash areas, and food carts. Rectal swabs were obtained from four consenting farm workers and one family member. All samples were cultured on MacConkey agar (Oxoid) plates containing cefotaxime (2 μg/ml). Air samples were obtained by exposing cefotaxime plates to air for 1 h. The identification of colonies with typical E. coli morphology was confirmed by the citrate, indole, methyl red, and Voges-Proskauer tests. The presence of blaCTX-M-1 was determined by PCR using CTX-M universal primers (9) and by DNA sequencing using CTX-M-1-specific primers (F primer, 5′-CCATGGTTAAAAAATCACTGCG-3′, and R primer, 5′-GTRAARTARGTSACCAGAAYSAGCGG-3′). The 803-bp fragment (approximately 92% of the entire gene) displayed 100% nucleotide and predicted amino acid identity to blaCTX-M-1.

E. coli producing CTX-M-1 was detected at high frequencies in animal, human, and environmental samples from both farms (Table 1). Most pigs (56/70) harbored CTX-M-1-positive E. coli, including 20 of the 30 sow-piglet pairs tested. CTX-M-1-producers were also isolated from three of the four samples from the farm workers and from the manure and air samples but not from the surface swabs or from the sample from the family member, who did not have daily exposure to the pigs. Four E. coli phylogenetic groups (A, B1, B2, and D) were detected by multiplex PCR (60%, 22%, 6%, and 12%, respectively) (4) (Table 1). XbaI pulsed-field gel electrophoresis (PFGE) (3) was used to investigate the genetic diversity among the 55 typeable CTX-M-1-producing isolates (see Fig. S1 in the supplemental material). Nineteen isolates from the previous study (11) were included to assess the possible persistence of CTX-M-1-producing E. coli clones. PFGE cluster analysis (unweighted-pair group method using average linkages, Dice similarity coefficient, optimization, and position tolerance of 2%) was done by Gelcompar II (Applied Maths, Belgium), resulting in 15 PFGE types displaying less than 80% similarity and 63 subtypes showing minor band differences within PFGE types. Indistinguishable PFGE patterns were observed only in isolates from farm 2 on four occasions, including two piglet isolates from 2006 and one human isolate from 2007.

TABLE 1.

Occurrence and diversity of blaCTX-M-1-positive E. coli

Farm Sample type (no. of isolates) No. of blaCTX-M-1-positive PCR isolates No. of PFGE subtypesa E. coli phylotype(s) (no. of isolates)
1 Sow (20) 15 11, NT (4) A (7), B1 (4), B2 (2), D (2)
Piglets (20) 16 14, NT (2) A (11), B1 (4), D (1)
Surface swabs (7) 0
Air samples (7) 1 1 D (1)
Humans (1) 0
2 Sow (10) 10 10 A (7), B1 (2), D (1)
Piglets (10) 9 6, NT (1) A (4), B1 (5)
Weaners (10) 6 5, NT (1) A (3), B1 (2), B2 (1)
Manure (4) 2 2 A (1), B1 (1)
Surface swabs (8) 0
Air samples (9) 1 1 A (1)
Humans (4) 3 3 A (2), D(1)
Subtotal Pigs (70) 56 A (32), B1 (17), B2 (3), D (4)
Humans (5) 3 A (2), D (1)
Environment (35) 4 A (2), B1 (1), D (1)
a

See Fig. S1 in the supplemental material for complete PFGE dendrograms. NT indicates nontypeable isolates, and the number of nontypeable isolates is indicated in parentheses.

Antimicrobial susceptibility was performed on all CTX-M producers according to CLSI standards (5). Due to the absence of standard breakpoints for E. coli, resistance (R) to ceftiofur (R = 6 mm for all isolates), florfenicol (R = 6 mm; susceptibility/intermediate resistance [S/I] ≥ 15 mm) and spectinomycin (R ≤ 10 mm; S/I ≥ 12 mm) was defined based on cutoff values determined by the distribution of inhibition zone diameters. Such values were in agreement with the clinical breakpoints for animal respiratory pathogens (6). Most (80%) isolates were resistant to two or more non-β-lactam antimicrobial classes. The human isolates showed variable resistance profiles, but all were resistant to at least four antimicrobial classes, including aminoglycosides, phenicols, tetracyclines, and sulfamethoxazole-trimethoprim. Ten strains from each farm displaying diverse PFGE subtypes or strain origins (pig, human, or environmental) and three strains from 2006 (20) (Table 2) were selected for plasmid characterization. Plasmids mediating cefotaxime resistance were transformed into electrocompetent Genehog E. coli (Invitrogen) using a Bio-Rad gene pulser and analyzed by replicon PCR (1) and restriction fragment length polymorphism (RFLP) using HincII and EcoRV. All plasmids belonged to IncN, and most (19/23) of them were either indistinguishable or closely related (RFLP type A) (Table 2). Four variants of plasmid RFLP type A were found in E. coli isolates from farm 1 (A1 to A3) and farm 2 (A4). Such variants were characterized by equal size (approximately 45 kb), identical EcoRV patterns, and up to two or three band differences following digestion with HincII (data not shown). The remaining four transformants contained IncN plasmids with different RFLP patterns (B to E). On farm 2, the plasmid detected in all the farm workers, the air sample, the manure, and most of the pigs was identical to that identified in the isolate from 2006 (RFLP pattern A4) and related to those found on farm 1 in 2006 (RFLP pattern A3) and 2007 (RFLP patterns A1 and A2). The cotransfer of resistance to non-β-lactam antimicrobials was only observed for three plasmids, and the cotransferred resistance genes were identified by PCR (8, 12, 13, 15) (Table 2).

TABLE 2.

Characterization of IncN plasmids harboring blaCTX-M-1 by RFLP analysis and replicon typing

Strain Origin Farm E. coli phylotype PFGE subtype EcoRV plasmid RFLP HincII plasmid RFLP Cotransferred resistancea Coresistance genes
HA6 Slaughterb 1 A F1 I A3
6232P Piglet 1 A H2 I A1
6232S Sow 1 A H3 III C SXT, FFC, TET, CHL sul1, sul2, tetA, floR, catA1
1184S Sow 1 A I1 I A1
1285P Piglet 1 A J1 I A2
1233S Sow 1 B1 A1 II B SUL, FFC, CHL sul1, sul2, floR
1285S Sow 1 B1 A2 I A2
1184P Piglet 1 B1 B1 I A2
1170P Piglet 1 B1 C1 I A1
951P Piglet 1 D B2 I A1
Env1 Air 1 D B4 I A1
KV7 Pigletb 1 D G1 IV D
1484S Sow 1 D I2 I A2
Hu2 Human 2 A L4 I A4
FP7 Pigletb 2 A L4 I A4
Env2 Air 2 A L5 I A4
W3 Weaner 2 A L9 V E CHL, SPX, SXT sul1, sul3, cmlA, aadA
S2 Sow 2 A L16 I A4
Hu1 Human 2 A M1 I A4
Pen2 Slaughter 2 A M2 I A4
P2 Piglet 2 B1 L5 I A4
Pen4 Slaughter 2 B1 L10 I A4
Hu3 Human 2 D M6 I A4
a

CHL, chloramphenicol; FFC, florfenicol; SPX, spectinomycin; SUL, sulfamethoxazole; SXT, sulfamethoxazole-trimethoprim; TET, tetracycline.

b

Isolate data from Jørgensen et al. (11).

CTX-M-1-producing E. coli was widespread on the two farms. PFGE and plasmid analysis indicated that the spread of CTX-M-1-producing E. coli between pigs and farm workers was predominantly due to the horizontal dissemination of IncN plasmids among distinct E. coli lineages. This study illustrates that plasmids carrying ESBL genes of clinical interest can be easily transferred between animals and humans by direct contact. The high genetic diversity indicated that the spread of blaCTX-M-1 was not a result of clonal dissemination. Interestingly, even sows and piglets harbored distinct strains despite being housed together. The same PFGE pattern was occasionally observed in E. coli of porcine and human origin, suggesting that some strains may be able to exist in the intestinal tracts of both pigs and humans, thereby allowing plasmid transfer. The three farm workers harboring CTX-M-1-producing E. coli had no contact with hospitals and did not receive antimicrobials in the 6 months prior to sampling. Therefore, it is reasonable to assume that the farm workers acquired IncN plasmids carrying blaCTX-M-1 from pigs, where the presence of such plasmids was selected by antibiotic exposure.

The association between blaCTX-M-1 and IncN plasmids has previously been observed among porcine clinical E. coli isolates in Denmark (H. Hasman, unpublished data) and among human clinical isolates in Spain (16) and Italy (14). Less frequently, CTX-M-1 has been associated with other incompatibility groups, such as IncI1 in poultry in France (7) and IncL/M in human patients in Spain (16). The small band differences observed among the three most prevalent plasmids at farm 1 (RFLP patterns A1 to A3) and farm 2 (RFLP pattern A4) indicate that such plasmid variants may have originated from a common ancestor. The dissemination of this plasmid lineage in Danish pig farming could have been enhanced by the use of veterinary cephalosporins, as suggested by the fact that blaCTX-M-1 was the only detectable resistance gene. As indicated by the results of the previous cohort study (11), the high prevalences of CTX-M-1-producing E. coli observed among healthy pigs and farm workers in this study are likely to reflect the continuous selective pressure exerted through the prophylactic use of ceftiofur. The effects of veterinary cephalosporins on the selection of CTX-M-1-producing E. coli in the intestinal tracts of pigs have recently been illustrated under experimental conditions (2).

The spread of IncN plasmids carrying blaCTX-M-1 in pig farming may have significant implications for both human and animal health. Beside the zoonotic risk of transmission, there is also a concrete risk that IncN plasmids carrying blaCTX-M-1, which are typically conjugative and broad-host-range plasmids, are transferred from commensal E. coli to swine respiratory pathogens, thereby resulting in a veterinary therapeutic problem. On the basis of these considerations, ceftiofur and other veterinary cephalosporins should be used prudently in animal farming and prophylactic use should be avoided. More research is needed to assess the occupational health risks associated with the occurrence of CTX-M-1-producing E. coli in farm workers as well as to investigate the possible zoonotic transmission of IncN plasmids carrying blaCTX-M-1 through the food chain.

Supplementary Material

[Supplemental material]

Acknowledgments

The study was supported by the EU Marie Curie Early Stage Training program TRAINAU (contract MEST-CT-2004-007819).

We would like to thank Tina Struve and Søren Saxmose Nielsen for help with sampling and isolation and Henrik Hasman and Kristina Kadlec for assistance with plasmid characterization.

Footnotes

Published ahead of print on 2 February 2009.

Supplemental material for this article may be found at http://aac.asm.org/.

REFERENCES

  • 1.Carattoli, A., A. Bertini, L. Villa, V. Falbo, K. L. Hopkins, and E. J. Threlfall. 2005. Identification of plasmids by PCR-based replicon typing. J. Microbiol. Methods 63:219-228. [DOI] [PubMed] [Google Scholar]
  • 2.Cavaco, L. M., E. Abatih, F. M. Aarestrup, and L. Guardabassi. 2008. Selection and persistence of CTX-M-producing Escherichia coli in the intestinal flora of pigs treated with amoxicillin, ceftiofur, or cefquinome. Antimicrob. Agents Chemother. 52:3612-3616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Centers for Disease Control and Prevention. 2004. Standardized molecular subtyping of foodborne bacterial pathogens by pulsed-field gel electrophoresis. The national molecular subtyping network for foodborne disease surveillance. Centers for Disease Control and Prevention, Atlanta, GA.
  • 4.Clermont, O., S. Bonacorsi, and E. Bingen. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66:4555-4558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial disk susceptibility tests, 9th ed. Approved standard M2-A9. Clinical and Laboratory Standards Institute, Wayne, PA.
  • 6.Clinical and Laboratory Standards Institute. 2008. Performance standards for antimicrobial disk susceptibility tests for bacteria isolated from animals, 3rd ed. Approved standard M31-A3. Clinical and Laboratory Standards Institute, Wayne, PA.
  • 7.Girlich, D., L. Poirel, A. Carattoli, I. Kempf, M. F. Lartigue, A. Bertini, and P. Nordmann. 2007. Extended-spectrum β-lactamase CTX-M-1 in Escherichia coli isolates from healthy poultry in France. Appl. Environ. Microbiol. 73:4681-4685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Grape, M., L. Sundström, and G. Kronvall. 2003. Sulphonamide resistance gene sul3 found in Escherichia coli isolates from human sources. J. Antimicrob. Chemother. 52:1022-1024. [DOI] [PubMed] [Google Scholar]
  • 9.Hasman, H., D. Mevius, K. Veldman, I. Olesen, and F. M. Aarestrup. 2005. β-Lactamases among extended-spectrum β-lactamase (ESBL)-resistant Salmonella from poultry, poultry products and human patients in The Netherlands. J. Antimicrob. Chemother. 56:115-121. [DOI] [PubMed] [Google Scholar]
  • 10.Jiang, X., H. Yang, B. Dettman, and M. P. Doyle. 2006. Analysis of fecal microbial flora for antibiotic resistance in ceftiofur-treated calves. Foodborne Pathog. Dis. 3:355-365. [DOI] [PubMed] [Google Scholar]
  • 11.Jørgensen, C. J., L. M. Cavaco, H. Hasman, H. D. Emborg, and L. Guardabassi. 2007. Occurrence of CTX-M-1-producing Escherichia coli in pigs treated with ceftiofur. J. Antimicrob. Chemother. 59:1040-1042. [DOI] [PubMed] [Google Scholar]
  • 12.Kadlec, K., C. Kehrenberg, and S. Schwarz. 2005. Molecular basis of resistance to trimethoprim, chloramphenicol and sulphonamides in Bordetella bronchiseptica. J. Antimicrob. Chemother. 56:485-490. [DOI] [PubMed] [Google Scholar]
  • 13.Kadlec, K., C. Kehrenberg, and S. Schwarz. 2007. Efflux-mediated resistance to florfenicol and/or chloramphenicol in Bordetella bronchiseptica: identification of a novel chloramphenicol exporter. J. Antimicrob. Chemother. 59:191-196. [DOI] [PubMed] [Google Scholar]
  • 14.Mugnaioli, C., F. De Luca, A. Carattoli, and G. M. Rossolini. 2006. Characterisation of conjugative plasmids encoding CTX-M-type extended-spectrum beta-lactamases in Italian clinical isolates of Escherichia coli. Clin. Microbiol. Infect. 12(Suppl. 4):24-25.16445721 [Google Scholar]
  • 15.Nawaz, M., K. Sung, S. A. Khan, A. A. Khan, and R. Steele. 2006. Biochemical and molecular characterization of tetracycline-resistant Aeromonas veronii isolates from catfish. Appl. Environ. Microbiol. 72:6461-6466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Novais, Â., R. Cantón, R. Moreira, L. Peixe, F. Baquero, and T. M. Coque. 2007. Emergence and dissemination of Enterobacteriaceae isolates producing CTX-M-1-like enzymes in Spain are associated with IncFII (CTX-M-15) and broad-host-range (CTX-M-1, -3, and -32) plasmids. Antimicrob. Agents Chemother. 51:796-799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Shiraki, Y., N. Shibata, Y. Doi, and Y. Arakawa. 2004. Escherichia coli producing CTX-M-2 beta-lactamase in cattle, Japan. Emerg. Infect. Dis. 10:69-75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Tragesser, L. A., T. E. Wittum, J. A. Funk, P. L. Winokur, and P. J. Rajala-Schultz. 2006. Association between ceftiofur use and isolation of Escherichia coli with reduced susceptibility to ceftriaxone from fecal samples of dairy cows. Am. J. Vet. Res. 67:1696-1700. [DOI] [PubMed] [Google Scholar]
  • 19.World Health Organization. 2005. Critically important antibacterial agents for human medicine for risk management strategies of nonhuman use: report of a WHO working group consultation, 15-18 February 2005, Canberra, Australia. World Health Organization, Geneva, Switzerland. http://www.who.int/foodborne_disease/resistance/FBD_CanberraAntibacterial_FEB2005.pdf.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

[Supplemental material]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES